Who we are

We are one of the only pharmaceutical companies in the world focused exclusively on brain diseases and our speciality sets us apart. Our purpose is clear:

For more than 70 years, we’ve been pushing the boundaries of neuroscience. By combining the logic of science with our passion for making a difference to patients, we’ve pioneered some of the most important and commonly used therapies within the antipsychotic and antidepressant markets.

We work closely with patients, healthcare professionals and the neuroscience community to help uncover causes and to find potential new treatments that can bring back quality of life to people living with brain diseases. 

As a global specialist, we owe it to those who live with brain diseases to fight stigma and promote improved treatment. That’s why we work to improve understanding and parity of care across communities and societies – so we can empower people and rebuild hope.

The Lundbeck Foundation is the majority owner of Lundbeck. Foundation ownership allows us to stay focused on our areas of specialty. It also means that we are in a position to give back. With donations of approximately DKK 500 million a year to biomedical research, the Foundation supports the progress of health science. 

Today, we’re 5,400 people in 50+ countries. We build on our Danish heritage, fostering a culture of collaboration and responsibility. Whether we work in labs or in the field, we all have the same aim: to develop innovative treatments that improve the lives of people living with brain diseases.